NNRTIs inhibit the activity of reverse transcriptase by binding to a specific site on the enzyme. This binding causes a structural alteration that prevents the enzyme from converting viral RNA into DNA, a critical step in the HIV replication process. By blocking this step, NNRTIs help to reduce the viral load in the patient's body, thereby improving immune function and reducing the risk of HIV-related complications.
